Tango Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Tango Therapeutics (NASDAQ: TNGX) has announced participation in two virtual investor conferences in February 2022. The Guggenheim 2022 Oncology Conference is scheduled for February 9 at 9:00 AM ET, followed by the 11th Annual SVB Leerink Global Healthcare Conference on February 16 at 1:00 PM ET. Live webcasts of these events will be available on the company's website, with replays accessible for 30 days post-event. Tango specializes in precision cancer medicines, employing innovative approaches to target cancer effectively.

CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that members of the management team are scheduled to participate in the following upcoming virtual investor conferences in February:

Guggenheim 2022 Oncology Conference
Date: Wednesday, February 9 2022
Time: 9:00 AM ET

11^th Annual SVB Leerink Global Healthcare Conference
Date: Wednesday, February 16 2022
Time: 1:00 PM ET

A live webcast of the fireside chats will be available under the "Events & Presentations" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcasts will be archived on the Company's website for 30 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

Investor Contact:
Sam Martin/Michael Barron
Argot Partners
tango@argotpartners.com

Media Contact:
Joshua R. Mansbach
Argot Partners
tango@argotpartners.com

FAQ

When is the Guggenheim 2022 Oncology Conference for TNGX?

The Guggenheim 2022 Oncology Conference is on February 9, 2022, at 9:00 AM ET.

What time is the SVB Leerink Global Healthcare Conference for TNGX?

The SVB Leerink Global Healthcare Conference is scheduled for February 16, 2022, at 1:00 PM ET.

Where can I watch the TNGX investor conference webcasts?

Webcasts can be viewed on the 'Events & Presentations' tab on Tango Therapeutics' website.

How long will the TNGX conference webcasts be available?

The webcasts will be archived for 30 days following the presentations.

What does Tango Therapeutics focus on?

Tango Therapeutics focuses on discovering and delivering next-generation precision cancer medicines.